Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial
Background:
At present, there is insufficient evidence to guide appropriate management of women with preterm prelabor rupture of membranes (PPROM) near term.
Methods and Findings:
We conducted an open-label randomized controlled trial in 60 hospitals in The Netherlands, which included non-laboring women with >24 h of PPROM between 34+0 and 37+0 wk of gestation. Participants were randomly allocated in a 1∶1 ratio to induction of labor (IoL) or expectant management (EM) using block randomization. The main outcome was neonatal sepsis. Secondary outcomes included mode of delivery, respiratory distress syndrome (RDS), and chorioamnionitis. Patients and caregivers were not blinded to randomization status. We updated a prior meta-analysis on the effect of both interventions on neonatal sepsis, RDS, and cesarean section rate.
From 1 January 2007 to 9 September 2009, 776 patients in 60 hospitals were eligible for the study, of which 536 patients were randomized. Four patients were excluded after randomization. We allocated 266 women (268 neonates) to IoL and 266 women (270 neonates) to EM. Neonatal sepsis occurred in seven (2.6%) newborns of women in the IoL group and in 11 (4.1%) neonates in the EM group (relative risk [RR] 0.64; 95% confidence interval [CI] 0.25 to 1.6). RDS was seen in 21 (7.8%, IoL) versus 17 neonates (6.3%, EM) (RR 1.3; 95% CI 0.67 to 2.3), and a cesarean section was performed in 36 (13%, IoL) versus 37 (14%, EM) women (RR 0.98; 95% CI 0.64 to 1.50). The risk for chorioamnionitis was reduced in the IoL group. No serious adverse events were reported.
Updating an existing meta-analysis with our trial results (the only eligible trial for the update) indicated RRs of 1.06 (95% CI 0.64 to 1.76) for neonatal sepsis (eight trials, 1,230 neonates) and 1.27 (95% CI 0.98 to 1.65) for cesarean section (eight trials, 1,222 women) for IoL compared with EM.
Conclusions:
In women whose pregnancy is complicated by late PPROM, neither our trial nor the updated meta-analysis indicates that IoL substantially improves pregnancy outcomes compared with EM.
Trial registration:
Current Controlled Trials ISRCTN29313500
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial. PLoS Med 9(4): e32767. doi:10.1371/journal.pmed.1001208
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001208
Souhrn
Background:
At present, there is insufficient evidence to guide appropriate management of women with preterm prelabor rupture of membranes (PPROM) near term.
Methods and Findings:
We conducted an open-label randomized controlled trial in 60 hospitals in The Netherlands, which included non-laboring women with >24 h of PPROM between 34+0 and 37+0 wk of gestation. Participants were randomly allocated in a 1∶1 ratio to induction of labor (IoL) or expectant management (EM) using block randomization. The main outcome was neonatal sepsis. Secondary outcomes included mode of delivery, respiratory distress syndrome (RDS), and chorioamnionitis. Patients and caregivers were not blinded to randomization status. We updated a prior meta-analysis on the effect of both interventions on neonatal sepsis, RDS, and cesarean section rate.
From 1 January 2007 to 9 September 2009, 776 patients in 60 hospitals were eligible for the study, of which 536 patients were randomized. Four patients were excluded after randomization. We allocated 266 women (268 neonates) to IoL and 266 women (270 neonates) to EM. Neonatal sepsis occurred in seven (2.6%) newborns of women in the IoL group and in 11 (4.1%) neonates in the EM group (relative risk [RR] 0.64; 95% confidence interval [CI] 0.25 to 1.6). RDS was seen in 21 (7.8%, IoL) versus 17 neonates (6.3%, EM) (RR 1.3; 95% CI 0.67 to 2.3), and a cesarean section was performed in 36 (13%, IoL) versus 37 (14%, EM) women (RR 0.98; 95% CI 0.64 to 1.50). The risk for chorioamnionitis was reduced in the IoL group. No serious adverse events were reported.
Updating an existing meta-analysis with our trial results (the only eligible trial for the update) indicated RRs of 1.06 (95% CI 0.64 to 1.76) for neonatal sepsis (eight trials, 1,230 neonates) and 1.27 (95% CI 0.98 to 1.65) for cesarean section (eight trials, 1,222 women) for IoL compared with EM.
Conclusions:
In women whose pregnancy is complicated by late PPROM, neither our trial nor the updated meta-analysis indicates that IoL substantially improves pregnancy outcomes compared with EM.
Trial registration:
Current Controlled Trials ISRCTN29313500
: Please see later in the article for the Editors' Summary
Zdroje
1. CoxSMWilliamsMLLevenoKJ 1988 The natural history of preterm ruptured membranes: what to expect of expectant management. Obstet Gynecol 71 558 562
2. GibbsRSBlancoJD 1982 Premature rupture of the membranes. Obstet Gynecol 60 671 679
3. MercerBMGoldenbergRLMeisPJMoawadAHShellhaasC 2000 The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 183 738 745
4. FurmanBShoham-VardiIBashiriAErezOMazorM 2000 Clinical significance and outcome of preterm prelabor rupture of membranes: population-based study. Eur J Obstet Gynecol Reprod Biol 92 209 216
5. GoldenbergRLNelsonKGDavisROKoskiJ 1984 Delay in delivery: influence of gestational age and the duration of delay on perinatal outcome. Obstet Gynecol 64 480 484
6. MercerBM 2003 Preterm premature rupture of the membranes. Obstet Gynecol 101 178 193
7. BuchananSLCrowtherCALevettKMMiddletonPMorrisJ 2010 Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev 2010 CD004735
8. ACOG Committee on Practice Bulletins-Obstetrics 2007 ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 109 1007 1019
9. Royal College of Obstetricians and Gynaecologists 2006 Preterm prelabour rupture of membranes. Guideline No. 44. Available: http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT44PretermPrelabourRupture2006.pdf. Accessed 1 September 2011
10. Nederlandse Vereniging voor Obstetrie en Gynaecologie 2002 [Rupture of membranes before onset of labor.] Available: http://nvog-documenten.nl/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=564. Accessed 1 September 2011
11. BuchananSCrowtherCMorrisJ 2004 Preterm prelabour rupture of the membranes: a survey of current practice. Aust N Z J Obstet Gynaecol 44 400 403
12. SmithGRafuseCAnandNBrennanBConnorsG 2005 Prevalence, management, and outcomes of preterm prelabour rupture of the membranes of women in Canada. J Obstet Gynaecol Can 27 547 553
13. van der HamDPNijhuisJGMolBWvan BeekJJOpmeerBC 2007 Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial). BMC Pregnancy Childbirth 7 11
14. Nederlandse Vereniging voor Obstetrie en Gynaecologie 2006 [Induction of labor.] Available: http://nvog-documenten.nl/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=689. Accessed 1 September 2011
15. MercerBMCrockerLGBoeNMSibaiBM 1993 Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 169 775 782
16. The Nordic Cochrane Centre 2011 RevMan, version 5.1 [computer program] Copenhagen The Cochrane Collaboration
17. HannahMEOhlssonAFarineDHewsonSAHodnettED 1996 Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 334 1005 1010
18. NaefRW3rdAllbertJRRossELWeberBMMartinRW 1998 Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol 178 126 130
19. NeerhofMGCravelloCHaneyEISilverRK 1999 Timing of labor induction after premature rupture of membranes between 32 and 36 weeks' gestation. Am J Obstet Gynecol 180 349 352
20. LevitonAAllredENKubanKCHechtJLOnderdonkAB 2010 Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr Res 67 95 101
21. O'SheaTMAllredENDammannOHirtzDKubanKC 2009 The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev 85 719 725
22. LauJMageeFQiuZHoubeJVon DadelszenP 2005 Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 193 708 713
23. AlexanderJMMcIntireDMLevenoKJ 1999 Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 94 274 278
24. KayemGBernier-DupreelleAGoffinetFCabrolDHaddadB 2010 Active versus expectant management for preterm prelabor rupture of membranes at 34–36 weeks of completed gestation: comparison of maternal and neonatal outcomes. Acta Obstet Gynecol Scand 89 776 781
25. HansenAKWisborgKUldbjergNHenriksenTB 2008 Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 336 85 87
26. BurnsCMRutherfordMABoardmanJPCowanFM 2008 Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 122 65 74
27. LucasAMorleyRColeTJ 1988 Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 297 1304 1308
28. ShapiroSM 2003 Bilirubin toxicity in the developing nervous system. Pediatr Neurol 29 410 421
29. NewmanTBLiljestrandPJeremyRJFerrieroDMWuYW 2006 Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354 1889 1900
30. MacKayDFSmithGCDobbieRPellJP 2010 Gestational age at delivery and special educational need: retrospective cohort study of 407,503 schoolchildren. PLoS Med 7 e1000289 doi:10.1371/journal.pmed.1000289
31. BoersKEVijgenSMBijlengaDvan der PostJABekedamDJ 2010 Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 341 c7087
32. KoopmansCMBijlengaDGroenHVijgenSMAarnoudseJG 2009 Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374 979 988
33. CoxSMLevenoKJ 1995 Intentional delivery versus expectant management with preterm ruptured membranes at 30–34 weeks' gestation. Obstet Gynecol 86 875 879
34. SpinnatoJAShaverDCBrayEMLipshitzJ 1987 Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstet Gynecol 69 196 201
35. IamsJDTalbertMLBarrowsHSachsL 1985 Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation versus use of steroids and timed delivery. Am J Obstet Gynecol 151 32 38
36. GariteTJFreemanRKLinzeyEMBralyPSDorchesterWL 1981 Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol 141 508 515
37. NelsonLHMeisPJHatjisCGErnestJMDillardR 1985 Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol 66 55 58
38. MorrisJMRobertsCLCrowtherCABuchananSLHenderson-SmartDJ 2006 Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060]. BMC Pregnancy Childbirth 6 9
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 4
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial
- The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
- Long-Term Exposure to Silica Dust and Risk of Total and Cause-Specific Mortality in Chinese Workers: A Cohort Study
- Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification